# Grace Therapeutics to Present Data on the Unmet Medical Needs and Potential Benefits of GTx-104 in the Treatment of aSAH at Upcoming Medical Conferences
Canonical URL: https://biopharmsignal.com/news/ACST/grace-therapeutics-to-present-data-on-the-unmet-medical-needs-and-potential-benefits-of-gtx-104-in-the-treatment-of-asah-at-upcoming-medical-conferences
Ticker: ACST
Company: Acasti Pharma
Source: Acasti Pharma
Published: 2026-03-19 12:00 EST
Original Source URL: https://www.gracetx.com
## Article Body
No article body is available yet.
## Recent Company News
- 2026-07-28 11:00 EST — [Grace Therapeutics Announces Receipt of Type A Meeting Minutes from U.S. Food and Drug Administration](https://biopharmsignal.com/news/ACST/grace-therapeutics-announces-receipt-of-type-a-meeting-minutes-from-u-s-food-and-5b4963b2) — Source: Acasti Pharma
- 2026-06-18 12:00 EST — [Grace Therapeutics Announces 2026 Fiscal Year-End Financial Results, Provides Business Update](https://biopharmsignal.com/news/ACST/grace-therapeutics-announces-2026-fiscal-year-end-financial-results-provides-bus-86a698f4) — Source: Acasti Pharma
- 2026-04-23 17:13 EST — [Grace Therapeutics Provides Regulatory Update on New Drug Application for GTx-104](https://biopharmsignal.com/news/ACST/grace-therapeutics-provides-regulatory-update-on-new-drug-application-for-gtx-104) — Source: Acasti Pharma
- 2026-04-14 12:00 EST — [Grace Therapeutics Announces Abstract Highlighting STRIVE-ON Phase 3 Trial Results Accepted for Presentation at AAN 2026](https://biopharmsignal.com/news/ACST/grace-therapeutics-announces-abstract-highlighting-strive-on-phase-3-trial-results-accepted-for-presentation-at-aan-2026) — Source: Acasti Pharma
- 2026-03-19 12:00 EST — [Grace Therapeutics to Present Data on the Unmet Medical Needs and Potential Benefits of GTx-104 in the Treatment of aSAH at Upcoming Medical Conferences](https://biopharmsignal.com/news/ACST/grace-therapeutics-to-present-data-on-the-unmet-medical-needs-and-potential-benefits-of-gtx-104-in-the-treatment-of-asah-at-upcoming-medical-conferences) — Source: Acasti Pharma
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)